This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Fred's Stock Jumps Over 13% in a Day, 2 Things You Must Note
by Zacks Equity Research
Fred's (FRED) has rescheduled its earnings announcement date.This is solely connected to Fred's plans to divest its specialty pharmacy business.
Factors Setting the Stage for Fred's (FRED) in Q4 Earnings
by Zacks Equity Research
Fred's (FRED) has been reeling under soft comparable store sales for quite some time now. Let's see if Fred???s strategic initiatives can provide any respite in Q4.
Rite Aid (RAD) Reports Narrower-Than-Estimated Loss in Q4
by Zacks Equity Research
Rite Aid (RAD) reports better-than-expected bottom-line results for fourth-quarter fiscal 2018, while sales disappoint. Improvement in reimbursement rates aid results.
Rite Aid-Albertsons Merger Crosses First Antitrust Hurdle
by Zacks Equity Research
Rite Aid (RAD) successfully crosses the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, taking its first step toward merger with Albertsons.
Rite Aid (RAD) Completes Agreed Store Transfers to Walgreens
by Zacks Equity Research
Rite Aid (RAD) completes the agreed transfer of 1,932 stores to Walgreens. It expects to start transferring the three distribution centers by Sep 1.
Will Rite Aid's (RAD) Soft Sales Hurt Earnings Again in Q4?
by Zacks Equity Research
Rite Aid (RAD) is grappling with dismal sales trends lately, which is also weighing upon its bottom lines. Lower comps and decline in revenues at key business segments are hurting the top line.
Can Strategic Efforts Aid Fred's to Achieve a Turnaround?
by Zacks Equity Research
Fred's (FRED) focuses on pharmacy organization and expense reduction to achieve turnaround. However, receding comps continue to hurt.
Rite Aid Nears Completion of Assets Transfer to Walgreens
by Zacks Equity Research
Rite Aid (RAD) has transferred 1,651 stores and related assets to Walgreens Boots Alliance, thus nearing the completion of the commitment.
Retail Transition Brings Opportunities for Industry Players
by Zacks Equity Research
Consumers will gain from a slate of increasing options as retailers continue to reform their businesses with both online and in-store operations.
Retail 2018: Are Retailers' Problems Really Over?
by Zacks Equity Research
While the overall outlook for the sector has been rosy following a spectacular holiday season, retailers may still have some challenges to face.
Stock Market News For Feb 22, 2018
by Zacks Equity Research
Markets ended in negative territory on Wednesday following the release of minutes from Fed???s latest policy meeting.
Rite Aid (RAD) on Track with Asset Sale: Is it Aiding Stock?
by Zacks Equity Research
Rite Aid Corporation (RAD) is on track with the process of transferring stores and related assets to Walgreens under its amended and restated asset purchase agreement.
The Secret Winners from Amazon's Second Headquarters Shortlist
by Ryan McQueeney
Amazon announced its shortlist of 20 cities for its second headquarters. We have seen city officials do most of the campaigning so far, but here are some businesses that might benefit from having Amazon has a neighbor.
Fred's (FRED) Sluggish Store Sales Keep Investors at Bay
by Zacks Equity Research
Fred's (FRED) continues to witness dismal comps and store closures. Also, cancelled dividend and merger deal make this retailer a less-favored pick.
Rite Aid (RAD) Soars Too High Too Fast: Is This Justified?
by Zacks Equity Research
Rite Aid Corporation (RAD) stock seems to have gained solid momentum following the recent sale of stores to Walgreens. However, the company has been facing issues with dismal sales, heavy debt burden and strained margins.
Company News For January 5, 2018
by Zacks Equity Research
Companies In The News are:
Rite Aid (RAD) Q3 Earnings Beat, Stores Transfer on Track
by Zacks Equity Research
Rite Aid Corporation (RAD) reported third-quarter fiscal 2018 results, which marked a considerable improvement from the company's recent trend. Further, it continues to transfer stores to Walgreens.
Will Rite Aid's (RAD) Strategies Aid Earnings Growth in Q3?
by Zacks Equity Research
Rite Aid Corporation (RAD) is slated to report third-quarter fiscal 2018 results on Jan 3. After the aforementioned sale of stores to Walgreens, Rite Aid is poised to improve financial leverage and balance sheet.
Fred's Tanks 79% in a Year: Any Chances of Revival Ahead?
by Zacks Equity Research
Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.
Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings
by Zacks Equity Research
Fred's (FRED) third-quarter fiscal 2017 performance is expected to be hurt by dismal comps trend.
Rite Aid (RAD) Soars: Stock Adds 14.3% in Session
by Zacks Equity Research
Rite Aid (RAD) was a big mover last session, as the company saw its shares rise more than 14% on the day amid huge volumes.
Stock Market News For Oct 20, 2017
by Zacks Equity Research
Robust third-quarter earnings results provided a fillip to the equity market, but, the Nasdaq bucked the broader trend to finish lower as Apple slumps
Rite Aid (RAD) Sharpens Edge: Adds Apple Pay Option Online
by Zacks Equity Research
Accepting Apple Pay on its site is likely to be beneficial to Rite Aid Corporation (RAD), which seems to be the first pharmacy retailer to use this payment option online.
Rite Aid Stock Down 80% This Year: Is Amazon the Only Threat?
by Zacks Equity Research
Amazon's expansion strategy is not the only reason behind Rite Aid's (RAD) debacle. Let's take a look at the other reasons for which this stock has lost ground.
Rite Aid (RAD) Slumps 14% Since Q2 Loss: What Lies Ahead?
by Zacks Equity Research
Rite Aid Corporation (RAD), which had quite an eventful journey of late, reported dismal second-quarter fiscal 2018 results last week. However, latest deal with Walgreens should benefit.